We began by focusing on the development of a personal brand on
LinkedIn and
Twitter among individuals in the scientific and healthcare fields who could benefit from Sergey's research. This group comprised neuroscientists, machine and deep learning researchers, and professionals in hospitals and medical diagnostic labs, mainly from the USA and Western Europe.
It should be noted that LinkedIn was more appropriate for B2B communication, while Twitter was popular among the scientific community.